Article -> Article Details
Title | Global Cell Dissociation Market Analysis, Trends, Business Opportunities and Forecast to 2021 – 2026 |
---|---|
Category | Fitness Health --> Health Articles |
Meta Keywords | Cell Dissociation Market |
Owner | Healthcare101 |
Description | |
The Global
Cell Dissociation Market size is projected to reach USD 561 million by
2026 from USD 282 million in 2021, at a CAGR of 14.7% during the forecast
period. Factors such as growing government support for cell-based research, increasing
research and development initiatives by biopharmaceutical companies and a
growing focus on personalized medicine wherein cell dissociation plays a vital
role are driving the growth of this market. However, the cell-based research
activities are associated with high costs which is expected to restrain the
market growth to certain extent. Key Players: Thermo Fisher Scientific (US), Becton, Dickinson and Company
(US), Roche Diagnostics (Switzerland), Cytiva (a part of Danaher Corporation)
(US), STEMCELL Technologies (Canada), Miltenyi Biotec (Germany), and PromoCell
GmbH (Germany) etc. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=97548003 Global Cell dissociation Market Dynamics DRIVER: Growth in research and development initiatives by
biopharmaceutical companies The top companies in the biopharmaceutical industry are
focusing on R&D in various therapeutic areas to introduce new drugs in the
market. Therefore, there have been heavy investments in various research
activities such as clinical trials, efficacy studies, and toxicity studies.
Most of these studies require tissue dissociation products in order to isolate
cells from primary tissues. This is likely to boost the demand for cell
dissociation products. OPPORTUNITY: Emerging economies Emerging economies, such as China, India, and Brazil, are
expected to offer significant growth opportunities for players operating in the
cell dissociation market. There has been a rise in the R&D projects in the
life sciences field in these countries. For instance, pharmaceutical companies
based in India are making significant investments in R&D to introduce new
drugs into the market. Cadila Healthcare Ltd., an India-based pharmaceutical
company, spent USD 113 million on R&D in 2020, an increase of 13% over
2019. Similarly, Biocon, another India-based pharmaceutical company, spent USD
58.79 million on R&D in 2020, an increase of 52% over 2019. Such
investments are expected to increase the demand for cell dissociation products
in the country. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=97548003 CHALLENGE: Ethical concerns associated with research in
cell biology The cell biology research necessitates the use of animals
and humans, as animal and human cells are used in gene therapy studies that
involve the recombination of genes and stem cell research therapies. These
animal and human cells are also used for in vivo toxicity and pharmacokinetic
testing of drugs. This is because direct human or animal testing would be
harmful and even fatal. Additionally, stem cell research studies use human
embryos for clinical applications that often lead to their destruction. In
order to monitor these activities, strict regulations have been formulated by
ethical authorities in various countries across the globe. Authorities such as
the Human Tissue Authority (HTA), Human Fertilization and Embryology Authority
(HFEA), Medicines and Healthcare products Regulatory Agency (MHRA), and Central
Ethics Committee for Stem Cell Research (ZES), among others, have implemented
stringent regulations for cell biology research. These ethical concerns and
restrictions on the use of cells for research are limiting cell biology
research to a great extent in various countries across the globe. North America accounted for the largest share of the cell
dissociation market in 2020 Based on the region, the cell dissociation market is
segmented into North America, Europe, Asia Pacific, and the Rest of the World
(RoW). In 2020, North America accounted for the largest share of the cell
dissociation market. The large share of North America can primarily be
attributed to the increasing research in pharmaceutical and biotechnology industries
and the dominant presence of key market players in this region. Frequently Asked Questions (FAQ): ·
What is the projected market value of the global
cell dissociation market? ·
What is the estimated growth rate (CAGR) of the
global cell dissociation market for the next five years? ·
Who are the major players offering cell
dissociation in the market? ·
Which type segment of the global cell
dissociation market is expected to witness the highest growth? ·
Which end user segment is expected to grow at
the highest CAGR during the forecast period? Speak To Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=97548003 |